On Invalid Date, Nautilus Biotechnology (NASDAQ: NAUT) reported Q4 2023 earnings per share (EPS) of -$0.14, up 40% year over year. Total Nautilus Biotechnology earnings for the quarter were -$17.02 million. In the same quarter last year, Nautilus Biotechnology's earnings per share (EPS) was -$0.10.
As of Q2 2024, Nautilus Biotechnology's earnings has grown year over year. Nautilus Biotechnology's earnings in the past year totalled -$63.68 million.
What is NAUT's earnings date?
Nautilus Biotechnology's earnings date is Invalid Date. Add NAUT to your watchlist to be reminded of NAUT's next earnings announcement.
What was NAUT's revenue last quarter?
On Invalid Date, Nautilus Biotechnology (NASDAQ: NAUT) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Nautilus Biotechnology's revenue was $0.00.
What was NAUT's revenue growth in the past year?
As of Q2 2024, Nautilus Biotechnology's revenue has grown null year over year. Nautilus Biotechnology's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.